Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precis...

FDA Device Recall #Z-0601-2019 — Class III — October 5, 2018

Recall Summary

Recall Number Z-0601-2019
Classification Class III — Low risk
Date Initiated October 5, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Tosoh Bioscience Inc
Location Grove City, OH
Product Type Devices
Quantity 1000

Product Description

Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testing procedures for HbA1c quantitation.

Reason for Recall

Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If degradation of these controls occurs, P00 peaks may be seen and the % HbA1c control values may drift higher than the assigned range. This may result in delays when performing routine instrument quality control. If this issue occurs, there may be a delay in testing and reporting patient test results. Tosoh has received two (2) complaints related to this issue with no serious injuries reported.

Distribution Pattern

Distributed nationwide. Foreign distribution to Canada.

Lot / Code Information

Lot 7055

Other Recalls from Tosoh Bioscience Inc

Recall # Classification Product Date
Z-2968-2020 Class II Tosoh Bioscience AIA-PACK BHCG Calibration Veri... Aug 7, 2020
Z-2967-2020 Class II Tosoh Bioscience AIA- PACK HCG Calibrator Set-I... Aug 7, 2020
Z-2423-2020 Class II AIA-900 Analyzer, Part no. 022930, UDI 04560189... May 22, 2020
Z-1420-2020 Class II AIA-360 Automated Immunoassay Analyzer, Product... Jan 10, 2020
Z-0676-2019 Class II ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hor... Nov 30, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.